Efficacy, Safety, and Patient-Reported Outcomes in Patients with Moderate-to-Severe Plaque Psoriasis Treated with Brodalumab for 5 Years in a Long-Term, Open-Label, Phase II Study

Overview of attention for article published in American Journal of Clinical Dermatology, November 2019

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (70th percentile)

Mentioned by

blogs: 1 blog

facebook: 1 Facebook page

Citations

dimensions_citation: 32 Dimensions

Readers on

mendeley: 63 Mendeley

Summary Blogs Facebook Dimensions citations

So far, Altmetric has seen 1 blog post.

Efficacy, Safety And Patient-Reported Outcomes in Patients With Moderate-to-Severe Plaque Psoriasis

Physician's Weekly, 08 Nov 2021

Chronic inflammatory disorders such as psoriasis need therapy alternatives that retain effectiveness and tolerability over time.